Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of EMpagliflozin on Cardiac Function and Biomarkers of Heart Failure in Patients With Acute MYocardial Infarction

NCT03087773 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT03087773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03087773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of EMpagliflozin on Cardiac Function and Biomarkers of Heart Failure in Patients With Acute MYocardial Infarction
Lead sponsor
Medical University of Graz
Phase
Phase 3
Overall status
Completed
Start date
May 11, 2017
Completion date
May 17, 2022
Enrollment
476 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction